• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Caplin Point Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4464.0
  • ISIN : INE475E01026
2,109.10 30 (1.44%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    2,074.30

  • Today’s High

    2,123.00

  • Open

    2,080.00

  • Perv Close

    2,079.20

  • 52W Low

    1,422.15

  • 52W High

    2,641.00

Key Indicators

  • P/E(TTM)

    47.15

  • Mar.Cap (₹Cr.)

    16,031.63

  • Div & Yield %

    0.26

  • Book Value(₹)

    223.77

  • Debt-Equity Ratio

    1.44

  • AGM Date

    23-Jul-2025

  • EPS

    44.66

  • P/E Ratio

    47.15

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    16,031.63

  • RONW (%)

    24.52

  • ROCE (%)

    26.67

Score Board

  • Equity (₹ in Cr.)

    15.20

  • BV (₹)

    223.80

  • Sales( ₹ in Cr.)

    752.41

  • NP (in Cr.)

    339.49

  • NP Var(%)

    20.0

  • Div%

    275.0

  • CPS (₹)

    47.90

  • EPS (₹)

    44.70

  • Traded Value (₹ in Lakhs)

    16,004.26

  • 52 Week High

    2,641.00

  • 52 Week Low

    1,422.15

  • Price BSE

    2106.0

  • Price NSE

    2,109.00

  • Market Capital( in Cr.)

    16,004.26

  • P/C Ratio

    43.90

  • P/E Ratio

    47.20

  • Price Vs.BV

    44.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 625.09 528.61 528.06 482.68 527.83 536.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 625.09 528.61 528.06 482.68 527.83 536.91
Other Income 105.84 99.00 56.55 18.62 65.97 35.40
Stock Adjustments 43.68 1.67 9.00 0.57 0.74 2.51
Total Income 774.61 629.28 593.61 501.87 594.54 574.82
EXPENDITURE :            
Raw Materials 248.90 199.73 213.65 195.40 238.92 239.54
Power and Fuel Cost 15.43 9.89 9.54 6.36 7.19 12.29
Employee Cost 38.11 36.68 30.47 26.59 25.00 42.01
Other Manufacturing Expenses 25.43 13.73 10.81 7.75 8.98 15.56
Selling and Administration Expenses 39.86 40.30 43.51 28.12 38.19 39.24
Miscellaneous Expenses 13.96 10.03 9.46 5.10 3.29 2.17
Employee Benefit Expenses 38.11 36.68 30.47 26.59 25.00 42.01
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 381.69 310.36 317.44 269.32 321.57 350.82
Operating Profit 392.92 318.92 276.17 232.55 272.97 224.00
Interest 0.10 0.12 0.09 0.17 0.19 0.50
Gross Profit 392.82 318.80 276.08 232.38 272.78 223.50
Depreciation 27.08 25.65 25.77 22.44 19.65 20.84
Profit Before Tax 365.74 293.15 250.31 209.94 253.13 202.66
Current Tax 86.12 66.58 61.62 54.88 55.89 54.11
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.09 -7.69 0.82 -1.17 -0.40 0.38
Reported Net Profit 283.71 234.26 187.87 156.23 197.64 148.17
Extraordinary Items 1.19 1.17 0.75 4.67 3.75 1.32
Adjusted Net Profit 282.52 233.09 187.12 151.56 193.89 146.85
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,083.95 880.01 714.84 561.64 396.53 263.48
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 34.17 30.32 22.70 3.03 32.53 15.12
P & L Balance carried down 1,333.49 1,083.95 880.01 714.84 561.64 396.53
Dividend 15.19 15.16 11.35 0.00 15.88 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 225.00 200.00 150.00 125.00 110.00
Dividend Per Share(Rs) 5.00 4.50 4.00 3.00 2.50 2.20
Earnings Per Share-Unit Curr 37.35 30.86 24.78 20.65 26.13 19.59
Earnings Per Share(Adj)-Unit Curr 37.35 30.86 24.78 20.65 26.13 19.59
Book Value 183.03 150.19 122.78 100.29 79.31 57.13
Book Value(Adj)-Unit Curr 183.03 150.19 122.78 100.29 79.31 57.13

Shareholding Pattern

  • Promoter Group

    70.56%

  • Public Share Holding

    29.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,487,000 3.27 2,487,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,995,982 67.09 50,995,982 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,632,982 70.56 53,632,982 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,550 0.00 3,550 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,666,027 6.14 4,666,027 159
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 20,610 0.03 20,610 2
Insurance Companies 165,116 0.22 165,116 9
Mutual Funds / UTI 1,467,140 1.93 1,467,140 17
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 55,154 0.07 55,154 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,377,597 8.39 6,377,597 198
2] Non Institution
Bodies Corporate 719,130 0.95 714,130 367
Clearing Members 2,359 0.00 2,359 3
Directors of their Relatives 105,750 0.14 105,750 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,055,589 1.39 1,050,589 2,808
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 306,028 0.40 306,028 1,175
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,023,090 2.66 2,023,090 34
Individuals holding nominal share capital up to Rs. 1 lakh 8,864,052 11.66 8,209,407 89,500
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 19,885 0.03 19,885 6
Others 2,144,704 2.82 2,094,704 4
Sub Total 16,001,117 21.05 15,286,472 93,964
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,011,696 100.00 75,297,051 94,169

Company Background

Caplin Point Laboratories LtdPharmaceuticals - Indian - Formulations

  • Caplin Point Laboratories Ltd
  • BSE Code : 4464.0
  • ISIN : INE475E01026

  • Incorporation Year

    1990

  • Registered Office

    Ashvich Towers 3rd Floor
    No 3 Developed Plots Ind Estat, Chennai,
    Tamil Nadu-600096

  • Telephone

    91-44-24968000/71148000/28156653

  • FAX

    91-44-28154952

  • Chairman

    C C Paarthipan

  • Managing Director

    Sridhar Ganesan

  • Company Secretary

    Venkatram G

  • Auditor

    Brahmayya & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

Caplin Point Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Caplin Point Lab 2,105.50 730.93 625.09 47.15 28.84
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10